1
|
Kumon H, Yoshino Y, Funahashi Y, Mori H, Ueno M, Ozaki Y, Yamazaki K, Ochi S, Mori T, Iga JI, Nagai M, Nomoto M, Ueno SI. PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression. J Alzheimers Dis 2021; 79:1055-1062. [PMID: 33386803 PMCID: PMC7990403 DOI: 10.3233/jad-201046] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
BACKGROUND Phosphatidylinositol-binding clathrin assembly protein (PICALM) is a validated genetic risk factor for late-onset Alzheimer's disease (AD) and is associated with other neurodegenerative diseases. However, PICALM expression in the blood of neurodegenerative diseases remains elusive. OBJECTIVE This study aimed to assess the usefulness of PICALM expression levels in the blood of patients with AD, Parkinson's disease (PD), dementia with Lewy bodies (DLB), and geriatric major depressive disorder (MDD) as a diagnostic biomarker. METHODS In total, 45, 20, 21, and 19 patients with AD, PD, DLB, and geriatric MDD, respectively, and 54 healthy controls (HCs) were enrolled in the study. Expression data from Gene Expression Omnibus database (GSE97760), (GSE133347) and (GSE98793), (GSE48350), and (GSE144459) were used to validate the ability of biomarkers in the blood of patients with AD, PD, geriatric MDD, and a postmortem human AD brain and animal model of AD (3xTg-AD mouse), respectively. RESULTS PICALM mRNA expression in human blood was significantly increased in patients with AD compared with that in HCs. PICALM mRNA expression and age were negatively correlated only in patients with AD. PICALM mRNA expression in human blood was significantly lower in patients with PD than in HCs. No changes in PICALM mRNA expression were found in patients with DLB and geriatric MDD. CONCLUSION PICALM mRNA expression in blood was higher in patients with AD, but lower in patients with PD, which suggests that PICALM mRNA expression in human blood may be a useful biomarker for differentiating neurodegenerative diseases and geriatric MDD.
Collapse
Affiliation(s)
- Hiroshi Kumon
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Yuta Yoshino
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Yu Funahashi
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Hiroaki Mori
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Mariko Ueno
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Yuki Ozaki
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Kiyohiro Yamazaki
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Shinichiro Ochi
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Takaaki Mori
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Jun-Ichi Iga
- Department of Neuropsychiatry, Molecules and Function, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Masahiro Nagai
- Department of Neurology and Clinical Pharmacology, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | - Masahiro Nomoto
- Department of Neurology and Clinical Pharmacology, Graduate School of Medicine, Ehime University, Toon, Ehime, Japan
| | | |
Collapse
|
2
|
Glyceraldehyde-3-phosphate Dehydrogenase is a Multifaceted Therapeutic Target. Pharmaceutics 2020; 12:pharmaceutics12050416. [PMID: 32370188 PMCID: PMC7285110 DOI: 10.3390/pharmaceutics12050416] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2020] [Revised: 04/28/2020] [Accepted: 05/01/2020] [Indexed: 02/07/2023] Open
Abstract
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a glycolytic enzyme whose role in cell metabolism and homeostasis is well defined, while its function in pathologic processes needs further elucidation. Depending on the cell context, GAPDH may bind a number of physiologically important proteins, control their function and correspondingly affect the cell’s fate. These interprotein interactions and post-translational modifications of GAPDH mediate its cytotoxic or cytoprotective functions in the manner of a Janus-like molecule. In this review, we discuss the functional features of the enzyme in cellular physiology and its possible involvement in human pathologies. In the last part of the article, we describe drugs that can be employed to modulate this enzyme’s function in some pathologic states.
Collapse
|
3
|
Kadri S, El Ayed M, Cosette P, Jouenne T, Elkhaoui S, Zekri S, Limam F, Aouani E, Mokni M. Neuroprotective effect of grape seed extract on brain ischemia: a proteomic approach. Metab Brain Dis 2019; 34:889-907. [PMID: 30796716 DOI: 10.1007/s11011-019-00396-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2018] [Accepted: 02/04/2019] [Indexed: 01/01/2023]
Abstract
Stroke is one of the leading causes of long-lasting disability in human and oxidative stress an important underlying cause. Molecular insights into pathophysiology of ischemic stroke are still obscure, and the present study investigated the protective effect of high dosage Grape Seed Extract (GSE 2.5 g/kg) on brain ischemia-reperfusion (I/R) injury using a proteomic approach. Ischemia was realized by occlusion of the common carotid arteries for 30 min followed by 1 h reperfusion on control or GSE pre-treated rats, and a label-free quantification followed by mass spectrometry analysis used to evaluate I/R induced alterations in protein abundance and metabolic pathways as well as the protection afforded by GSE. I/R-induced whole brain ionogram dyshomeostasis, ultrastructural alterations, as well as inflammation into hippocampal dentate gyrus area, which were evaluated using ICP-OES, transmission electron microscopy and immuno-histochemistry respectively. I/R altered the whole brain proteome abundance among which 108 proteins were significantly modified (35 up and 73 down-regulated proteins). Eighty-four proteins were protected upon GSE treatment among which 27 were up and 57 down-regulated proteins, suggesting a potent protective effect of GSE close to 78%of the disturbed proteome. Furthermore, GSE efficiently prevented the brain from I/R-induced ion dyshomeostasis, ultrastructural alterations, inflammatory biomarkers as CD56 or CD68 and calcium burst within the hippocampus. To conclude, a potent protective effect of GSE on brain ischemia is evidenced and clinical trials using high dosage GSE should be envisaged on people at high risk for stroke.
Collapse
Affiliation(s)
- Safwen Kadri
- Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia.
| | - Mohamed El Ayed
- Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia
| | - Pascal Cosette
- Plateforme Protéomique PISSARO, Institut de Recherche et d'Innovation Biomédicale, Normandie Université, Mont Saint Aignan, France
| | - Thierry Jouenne
- Plateforme Protéomique PISSARO, Institut de Recherche et d'Innovation Biomédicale, Normandie Université, Mont Saint Aignan, France
| | - Salem Elkhaoui
- Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia
| | - Sami Zekri
- Common Services Unit on Transmission Electron Microscopy, Faculty of Medicineof Tunis, University of Tunis El Manar, Bab Saâdoun, Tunis, Tunisia
| | - Ferid Limam
- Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia
| | - Ezzedine Aouani
- Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia
| | - Meherzia Mokni
- Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia
| |
Collapse
|
4
|
El Kadmiri N, El Khachibi M, Slassi I, El Moutawakil B, Nadifi S, Soukri A. Assessment of GAPDH expression by quantitative real time PCR in blood of Moroccan AD cases. J Clin Neurosci 2017; 40:24-26. [PMID: 28087189 DOI: 10.1016/j.jocn.2016.12.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2016] [Accepted: 12/27/2016] [Indexed: 10/20/2022]
Abstract
INTRODUCTION Neuroproteomics studies have showed the high affinity interactions between GAPDH - β-amyloid in Alzheimer disease. The aim of our study is to complete our previous studies by assessing the mechanism responsible of decreased expression of GAPDH protein in the blood of Moroccan AD cases probably due to an alteration at the transcriptional level or at the post translational level. METHODS The mRNA expression of GAPDH was assessed by quantitative real time PCR in AD cases and healthy controls. RESULTS Our result revealed a significant difference of mRNA expression level of GAPDH in AD cases as compared to healthy controls (P<0.05). CONCLUSION This data is consistent with several studies by showing the direct involvement of GAPDH in amyloid aggregation by undergoing several modifications, which influence its chemical structure and its biological activity.
Collapse
Affiliation(s)
- Nadia El Kadmiri
- IBN ZOHR University, Faculté Polydisciplinaire de Taroudant, B.P: 271, 83 000 Taroudant, Morocco; Hassan II University of Casablanca, Laboratory of Medical Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, 19 Rue Tarik Ibnou Ziad, B.P: 9154, Morocco.
| | - Meryam El Khachibi
- Hassan II University of Casablanca, Laboratory of Medical Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, 19 Rue Tarik Ibnou Ziad, B.P: 9154, Morocco
| | - Ilham Slassi
- Hassan II University of Casablanca, Laboratory of Medical Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, 19 Rue Tarik Ibnou Ziad, B.P: 9154, Morocco; Neurology Department, IBN ROCHD University, Hospital, rue des Hôpitaux, Casablanca, Morocco
| | - Bouchra El Moutawakil
- Hassan II University of Casablanca, Laboratory of Medical Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, 19 Rue Tarik Ibnou Ziad, B.P: 9154, Morocco; Neurology Department, IBN ROCHD University, Hospital, rue des Hôpitaux, Casablanca, Morocco
| | - Sellama Nadifi
- Hassan II University of Casablanca, Laboratory of Medical Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, 19 Rue Tarik Ibnou Ziad, B.P: 9154, Morocco
| | - Abdelaziz Soukri
- Laboratory of Physiology and Molecular Genetics, Faculty of Sciences Aïn Chock, Hassan II University, Casablanca, Morocco
| |
Collapse
|